相关实验视频
Updated: Jun 25, 2026

07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
梅罗-克拉夫兰酸对广泛耐药的Mycobacterium结核病菌是有效的
Jean-Emmanuel Hugonnet1, Lee W Tremblay, Helena I Boshoff
1Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
概括
由于BlaC酶,β-乳酸抗生素在对抗Mycobacterium结核病时失败. 将美罗与克拉夫兰酸结合使用,对抗耐药结核病菌株具有强烈活性.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 贝塔乳酸抗生素对Mycobacterium结核病菌是无效的.
- 这种blaC基因编码了一种β-乳酸酶,该基因能快速化这些抗生素.
- 碳烯类β-乳酸盐是BlaC.的不良基质.
研究的目的:
- 为了确定BlaC-meropenem复合物的结构.
- 为了评估与克拉夫兰酸结合的美罗因对M.结核病的疗效.
主要方法:
- 使用X射线晶体学以1.8安格斯特罗姆分辨率确定BlaC-meropenem共价复合物的3D结构.
- 进行了最小抑制度 (MIC) 测试,以评估美罗和克拉夫兰酸对M.结核病的活性.
- 培养物在有氧和无氧条件下生长,以模仿不同的生理状态.
主要成果:
- 确定了共价BlaC-meropenem复合物的三维结构.
- 梅罗因与克拉夫兰酸盐结合,对M.结核病 (MIC < 1μg/mL) 显示出强烈的活性.
- 该组合在14天内实现了有氧培养物的灭菌,并抑制了持久的无氧培养物.
- 对13种广泛耐药的M.结核菌株观察到活性,与敏感菌株相似.
结论:
- 梅罗因与β-乳糖酶抑制剂clavulanate结合时,是对M.结核病的一种有前途的治疗策略.
- 这种组合显示出治疗药物敏感和广泛耐药结核病患者的潜力.
- 美国食品和药物管理局批准的美罗和克拉夫兰酸盐的地位有助于潜在的临床应用.
相关概念视频
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
